Flash Note : Annual Financial Results 2023 – Significant Sales and EBITDA Growth – Outperformance against Target Sales
Flash Note : Annual Financial Results 2023 (Unaudited Financial Data) Paiania, February 28, 2024 - Lavipharm S.A. informs the investment community on the key financial figures for the fiscal year 2023 and the Group’s operational developments: Consolidated Sales from ongoing operations, excluding Rebate & Clawback, amounted to EUR...